The multifaceted role of the intestinal microbiota in colon cancer

Molecular Cell

Volumn 54, Issue 2, 2014, Pages 309-320

  Irrazábal, Thergiory ^a   Belcheva, Antoaneta ^a   Girardin, Stephen E ^a   Martin, Alberto ^a   Philpott, Dana J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BUTYRIC ACID; DNA GLYCOSYLTRANSFERASE; GLYCOGEN SYNTHASE KINASE 3BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 23; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E; PROTEIN KINASE B;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; AUTOIMMUNE DISEASE; BACTERIAL TRANSLOCATION; BACTEROIDES FRAGILIS; BYSTANDER EFFECT; CARCINOGENESIS; CELL JUNCTION; CHROMOSOMAL INSTABILITY; CHRONIC INFLAMMATION; CITROBACTER RODENTIUM; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CROHN DISEASE; DIET; DISEASE ASSOCIATION; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DYSBIOSIS; ENTERITIS; ENTEROCOCCUS FAECALIS; FAECALIBACTERIUM PRAUSNITZII; FUSOBACTERIUM NUCLEATUM; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENETICS; GENOMIC INSTABILITY; HELICOBACTER HEPATICUS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE INFECTION; INTESTINE POLYP; LAMINA PROPRIA; LIPID PEROXIDATION; MACROPHAGE; MICROBIAL COMMUNITY; MICROBIAL METABOLISM; MICROSATELLITE INSTABILITY; NEUTROPHIL; NONHUMAN; NUCLEOTIDE METABOLISM; OBESITY; ONCOGENE RAS; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; RECTUM CARCINOMA; REVIEW; SISTER CHROMATID EXCHANGE; SOMATIC MUTATION; TH17 CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; UNSCHEDULED DNA SYNTHESIS; UPREGULATION;

CARCINOGENESIS; COLITIS; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA DAMAGE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTESTINES; MICROBIOTA;

EID: 84899156759     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.03.039     Document Type: Review

References (130)

1. Akiyama Y., Sato H., Yamada T., Nagasaki H., Tsuchiya A., Abe R., Yuasa Y. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 1997, 57:3920-3923.
2. Alberts D.S., Martínez M.E., Roe D.J., Guillén-Rodríguez J.M., Marshall J.R., van Leeuwen J.B., Reid M.E., Ritenbaugh C., Vargas P.A., Bhattacharyya A.B., et al. Lack of effect of a high-fiber cereal supplement on therecurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N.Engl. J. Med. 2000, 342:1156-1162.
3. Allen I.C., Wilson J.E., Schneider M., Lich J.D., Roberts R.A., Arthur J.C., Woodford R.M., Davis B.K., Uronis J.M., Herfarth H.H., et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 2012, 36:742-754.
4. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
5. Arthur J.C., Perez-Chanona E., Mühlbauer M., Tomkovich S., Uronis J.M., Fan T.J., Campbell B.J., Abujamel T., Dogan B., Rogers A.B., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338:120-123.
6. Bashir M., Kingston D.G., Carman R.J., van Tassell R.L., Wilkins T.D. Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) by human fecal flora. Mutat. Res. 1987, 190:187-190.
7. Bonithon-Kopp C., Kronborg O., Giacosa A., Räth U., Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet 2000, 356:1300-1306. European Cancer Prevention Organisation Study Group.
8. Brentnall T.A., Crispin D.A., Bronner M.P., Cherian S.P., Hueffed M., Rabinovitch P.S., Rubin C.E., Haggitt R.C., Boland C.R. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996, 56:1237-1240.
9. Caderni G., De Filippo C., Luceri C., Salvadori M., Giannini A., Biggeri A., Remy S., Cheynier V., Dolara P. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 2000, 21:1965-1969.
10. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4:579-591.
11. Carman R.J., Van Tassell R.L., Kingston D.G., Bashir M., Wilkins T.D. Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutat. Res. 1988, 206:335-342.
12. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310:1504-1510.
13. Chang C.L., Marra G., Chauhan D.P., Ha H.T., Chang D.K., Ricciardiello L., Randolph A., Carethers J.M., Boland C.R. Oxidative stress inactivates the human DNA mismatch repair system. Am. J. Physiol. Cell Physiol. 2002, 283:C148-C154.
14. Chen G.Y., Liu M., Wang F., Bertin J., Núñez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J.Immunol. 2011, 186:7187-7194.
15. Choi S.W., Mason J.B. Folate status: effects on pathways of colorectal carcinogenesis. J.Nutr. 2002, 132(Suppl):2413S-2418S.
16. Christl S.U., Scheppach W., Kasper H. [Hydrogen metabolism in the large intestine-physiology and clinical implications]. Z.Gastroenterol. 1995, 33:408-413.
17. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
18. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
19. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., Huot L., Grandjean T., Bressenot A., Delanoye-Crespin A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J.Clin. Invest. 2013, 123:700-711.
20. Cuevas-Ramos G., Petit C.R., Marcq I., Boury M., Oswald E., Nougayrède J.P. Escherichia coli induces DNA damage invivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 2010, 107:11537-11542.
21. de Kok T.M., van Maanen J.M., Lankelma J., ten Hoor F., Kleinjans J.C. Electron spin resonance spectroscopy of oxygen radicals generated bysynthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging. Carcinogenesis 1992, 13:1249-1255.
22. Deplancke B., Finster K., Graham W.V., Collier C.T., Thurmond J.E., Gaskins H.R. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp. Biol. Med. (Maywood) 2003, 228:424-433.
23. Donohoe D.R., Collins L.B., Wali A., Bigler R., Sun W., Bultman S.J. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 2012, 48:612-626.
24. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
25. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
26. Endo Y., Marusawa H., Kou T., Nakase H., Fujii S., Fujimori T., Kinoshita K., Honjo T., Chiba T. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 2008, 135:889-898. e1-e3.
27. Erdman S.E., Rao V.P., Poutahidis T., Rogers A.B., Taylor C.L., Jackson E.A., Ge Z., Lee C.W., Schauer D.B., Wogan G.N., et al. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc. Natl. Acad. Sci. USA 2009, 106:1027-1032.
28. Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567:1-61.
29. Fardini Y., Wang X., Témoin S., Nithianantham S., Lee D., Shoham M., Han Y.W. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol. Microbiol. 2011, 82:1468-1480.
30. Fleisher A.S., Esteller M., Harpaz N., Leytin A., Rashid A., Xu Y., Liang J., Stine O.C., Yin J., Zou T.T., et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res. 2000, 60:4864-4868.
31. Freeman H.J. Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology 1986, 91:596-602.
32. Fukata M., Chen A., Vamadevan A.S., Cohen J., Breglio K., Krishnareddy S., Hsu D., Xu R., Harpaz N., Dannenberg A.J., et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-1881.
33. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory Tcells. Nature 2013, 504:446-450.
34. Garrett W.S., Punit S., Gallini C.A., Michaud M., Zhang D., Sigrist K.S., Lord G.M., Glickman J.N., Glimcher L.H. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 2009, 16:208-219.
35. Gibson G.R. Physiology and ecology of the sulphate-reducing bacteria. J.Appl. Bacteriol. 1990, 69:769-797.
36. Gill C.I., Rowland I.R. Diet and cancer: assessing the risk. Br.J.Nutr. 2002, 88(Suppl 1):S73-S87.
37. Grady W.M., Carethers J.M. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008, 135:1079-1099.
38. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., Taniguchi K., Yu G.Y., Osterreicher C.H., Hung K.E., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
39. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
40. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer 1993, 55:498-505.
41. Han Y.W., Ikegami A., Rajanna C., Kawsar H.I., Zhou Y., Li M., Sojar H.T., Genco R.J., Kuramitsu H.K., Deng C.X. Identification and characterization of a novel adhesin unique to oral fusobacteria. J.Bacteriol. 2005, 187:5330-5340.
42. Hatch F.T., Knize M.G., Colvin M.E. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency. Environ. Mol. Mutagen. 2001, 38:268-291.
43. Heerdt B.G., Houston M.A., Augenlicht L.H. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 1994, 54:3288-3293.
44. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 1998, 95:6870-6875.
45. Holme J.A., Hongslo J.K., Søderlund E., Brunborg G., Christensen T., Alexander J., Dybing E. Comparative genotoxic effects of IQ and MeIQ in Salmonella typhimurium and cultured mammalian cells. Mutat. Res. 1987, 187:181-190.
46. Hu B., Elinav E., Huber S., Booth C.J., Strowig T., Jin C., Eisenbarth S.C., Flavell R.A. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl. Acad. Sci. USA 2010, 107:21635-21640.
47. Hu B., Elinav E., Huber S., Strowig T., Hao L., Hafemann A., Jin C., Wunderlich C., Wunderlich T., Eisenbarth S.C., Flavell R.A. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. USA 2013, 110:9862-9867.
48. Hughes R., Cross A.J., Pollock J.R., Bingham S. Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 2001, 22:199-202.
49. Hussain S.P., Amstad P., Raja K., Ambs S., Nagashima M., Bennett W.P., Shields P.G., Ham A.J., Swenberg J.A., Marrogi A.J., Harris C.C. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000, 60:3333-3337.
50. Huycke M.M., Gaskins H.R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. (Maywood) 2004, 229:586-597.
51. Huycke M.M., Moore D.R. Invivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic. Biol. Med. 2002, 33:818-826.
52. Huycke M.M., Joyce W., Wack M.F. Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis. J.Infect. Dis. 1996, 173:743-746.
53. Huycke M.M., Moore D., Joyce W., Wise P., Shepard L., Kotake Y., Gilmore M.S. Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol. Microbiol. 2001, 42:729-740.
54. Ikegami A., Chung P., Han Y.W. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect. Immun. 2009, 77:3075-3079.
55. Jobin C. Colorectal cancer: CRC-all about microbial products and barrier function?. Nat Rev Gastroenterol Hepatol 2012, 9:694-696.
56. Jung Y.J., Isaacs J.S., Lee S., Trepel J., Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003, 17:2115-2117.
57. Kamada N., Núñez G. Regulation of the Immune System by the Resident Intestinal Bacteria. Gastroenterology 2014, Published online February 4, 2014. 10.1053/j.gastro.2014.01.060.
58. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57:808-811.
59. Kassie F., Rabot S., Kundi M., Chabicovsky M., Qin H.M., Knasmüller S. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis 2001, 22:1721-1725.
60. Katsurano M., Niwa T., Yasui Y., Shigematsu Y., Yamashita S., Takeshima H., Lee M.S., Kim Y.J., Tanaka T., Ushijima T. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene 2012, 31:342-351.
61. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D., et al. Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661-665.
62. Koshiji M., To K.K., Hammer S., Kumamoto K., Harris A.L., Modrich P., Huang L.E. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol. Cell 2005, 17:793-803.
63. Kostic A.D., Chun E., Robertson L., Glickman J.N., Gallini C.A., Michaud M., Clancy T.E., Chung D.C., Lochhead P., Hold G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013, 14:207-215.
64. Lakatos P.L., Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 2008, 14:3937-3947.
65. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546. MetaHIT consortium.
66. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomäki P., Sistonen P., Aaltonen L.A., Nyström-Lahti M., et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215-1225.
67. Leedham S.J., Graham T.A., Oukrif D., McDonald S.A., Rodriguez-Justo M., Harrison R.F., Shepherd N.A., Novelli M.R., Jankowski J.A., Wright N.A. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 2009, 136:542-550.e6.
68. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
69. Li Y., Deuring J., Peppelenbosch M.P., Kuipers E.J., de Haar C., van der Woude C.J. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis 2012, 33:1889-1896.
70. Lowe E.L., Crother T.R., Rabizadeh S., Hu B., Wang H., Chen S., Shimada K., Wong M.H., Michelsen K.S., Arditi M. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS ONE 2010, 5:e13027.
71. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J.Clin. Invest. 2011, 121:2111-2117.
72. Lundberg J.O., Weitzberg E., Cole J.A., Benjamin N. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2004, 2:593-602.
73. Lynch H.T., de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J.Med. Genet. 1999, 36:801-818.
74. Macfarlane S., Steed H., Macfarlane G.T. Intestinal bacteria and inflammatory bowel disease. Crit. Rev. Clin. Lab. Sci. 2009, 46:25-54.
75. Mandir N., Englyst H., Goodlad R.A. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development. Br. J. Nutr. 2008, 100:711-721.
76. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: Molecular basis of colorectal cancer. N.Engl. J. Med. 2009, 361:2449-2460.
77. Marra G., Jiricny J. DNA mismatch repair and colon cancer. Adv. Exp. Med. Biol. 2005, 570:85-123.
78. Medema J.P., Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011, 474:318-326.
79. Meira L.B., Bugni J.M., Green S.L., Lee C.W., Pang B., Borenshtein D., Rickman B.H., Rogers A.B., Moroski-Erkul C.A., McFaline J.L., et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J.Clin. Invest. 2008, 118:2516-2525.
80. Miquel S., Martín R., Rossi O., Bermúdez-Humarán L.G., Chatel J.M., Sokol H., Thomas M., Wells J.M., Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 2013, 16:255-261.
81. Nair J., Gansauge F., Beger H., Dolara P., Winde G., Bartsch H. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid. Redox Signal. 2006, 8:1003-1010.
82. Nesić D., Hsu Y., Stebbins C.E. Assembly and function of a bacterial genotoxin. Nature 2004, 429:429-433.
83. Nicolaides N.C., Kinzler K.W., Vogelstein B. Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. Genomics 1995, 29:329-334.
84. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665-669.
85. Norat T., Riboli E. Meat consumption and colorectal cancer: a review of epidemiologic evidence. Nutr. Rev. 2001, 59:37-47.
86. Pajari A.M., Rajakangas J., Päivärinta E., Kosma V.M., Rafter J., Mutanen M. Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int. J. Cancer 2003, 106:653-660.
87. Pekow J.R., Dougherty U., Mustafi R., Zhu H., Kocherginsky M., Rubin D.T., Hanauer S.B., Hart J., Chang E.B., Fichera A., et al. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm. Bowel Dis. 2012, 18:94-100.
88. Poulogiannis G., Frayling I.M., Arends M.J. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology 2010, 56:167-179.
89. Pruitt K., Der C.J. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 2001, 171:1-10.
90. Rakoff-Nahoum S., Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007, 317:124-127.
91. Robertson S.J., Zhou J.Y., Geddes K., Rubino S.J., Cho J.H., Girardin S.E., Philpott D.J. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 2013, 4:222-231.
92. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., Mazmanian S.K. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
93. Rubinstein M.R., Wang X., Liu W., Hao Y., Cai G., Han Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013, 14:195-206.
94. Rumney C.J., Rowland I.R., Coutts T.M., Randerath K., Reddy R., Shah A.B., Ellul A., O'Neill I.K. Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis 1993, 14:79-84.
95. Rustgi A.K. The genetics of hereditary colon cancer. Genes Dev. 2007, 21:2525-2538.
96. Salaspuro M. Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. Ann. Med. 1996, 28:195-200.
97. Salcedo R., Worschech A., Cardone M., Jones Y., Gyulai Z., Dai R.M., Wang E., Ma W., Haines D., O'hUigin C., et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J.Exp. Med. 2010, 207:1625-1636.
98. Sanfilippo L., Li C.K., Seth R., Balwin T.J., Menozzi M.G., Mahida Y.R. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells. Clin. Exp. Immunol. 2000, 119:456-463.
99. Schatzkin A., Lanza E., Corle D., Lance P., Iber F., Caan B., Shike M., Weissfeld J., Burt R., Cooper M.R., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N.Engl. J. Med. 2000, 342:1149-1155. Polyp Prevention Trial Study Group.
100. Schnupf P., Gaboriau-Routhiau V., Cerf-Bensussan N. Host interactions with Segmented Filamentous Bacteria: an unusual trade-off that drives the post-natal maturation of the gut immune system. Semin. Immunol. 2013, 25:342-351.
101. Schut H.A., Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 1999, 20:353-368.
102. Schwabe R.F., Jobin C. The microbiome and cancer. Nat. Rev. Cancer 2013, 13:800-812.
103. Seitz H.K., Simanowski U.A., Garzon F.T., Rideout J.M., Peters T.J., Koch A., Berger M.R., Einecke H., Maiwald M. Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat. Gastroenterology 1990, 98:406-413.
104. Senda T., Iizuka-Kogo A., Onouchi T., Shimomura A. Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Med. Mol. Morphol. 2007, 40:68-81.
105. Shaked H., Hofseth L.J., Chumanevich A., Chumanevich A.A., Wang J., Wang Y., Taniguchi K., Guma M., Shenouda S., Clevers H., et al. Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumorinitiation through iNOS up-regulation. Proc. Natl. Acad. Sci. USA 2012, 109:14007-14012.
106. Shanahan M.T., Carroll I.M., Grossniklaus E., White A., von Furstenberg R.J., Barner R., Fodor A.A., Henning S.J., Sartor R.B., Gulati A.S. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 2013, Published online March 19, 2013. 10.1136/gutjnl-2012-304190.
107. Shioya M., Wakabayashi K., Yamashita K., Nagao M., Sugimura T. Formation of 8-hydroxydeoxyguanosine in DNA treated with fecapentaene-12 and -14. Mutat. Res. 1989, 225:91-94.
108. Singh N., Gurav A., Sivaprakasam S., Brady E., Padia R., Shi H., Thangaraju M., Prasad P.D., Manicassamy S., Munn D.H., et al. Activation ofGpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40:128-139.
109. Sobko T., Reinders C.I., Jansson E., Norin E., Midtvedt T., Lundberg J.O. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide 2005, 13:272-278.
110. Sobko T., Huang L., Midtvedt T., Norin E., Gustafsson L.E., Norman M., Jansson E.A., Lundberg J.O. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic. Biol. Med. 2006, 41:985-991.
111. Strocchi A., Furne J., Ellis C., Levitt M.D. Methanogens outcompete sulphate reducing bacteria for H2 in the human colon. Gut 1994, 35:1098-1101.
112. Sugimura T., Sato S. Mutagens-carcinogens in foods. Cancer Res. 1983, 43(Suppl):2415s-2421s.
113. Takai A., Marusawa H., Minaki Y., Watanabe T., Nakase H., Kinoshita K., Tsujimoto G., Chiba T. Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene 2012, 31:1733-1742.
114. Wang X., Huycke M.M. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007, 132:551-561.
115. Wang D., Kreutzer D.A., Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 1998, 400:99-115.
116. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., Jia W., Cai S., Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012, 6:320-329.
117. Watson A.J., Collins P.D. Colon cancer: a civilization disorder. Dig. Dis. 2011, 29:222-228.
118. Westbrook A.M., Wei B., Braun J., Schiestl R.H. Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res. 2009, 69:4827-4834.
119. Westbrook A.M., Wei B., Braun J., Schiestl R.H. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int. J. Cancer 2011, 129:1815-1825.
120. Wild D., Kaiser G., King M.T., Harnasch D. Genotoxic activity of IQ (2-amino-3-methylimidazo [4,5-f]quinoline) and structural analogs. Prog. Clin. Biol. Res. 1986, 206:145-154.
121. Winter S.E., Lopez C.A., Bäumler A.J. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 2013, 14:319-327.
122. Winters M.D., Schlinke T.L., Joyce W.A., Glore S.R., Huycke M.M. Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancer. Am. J. Gastroenterol. 1998, 93:2491-2500.
123. Wu S., Morin P.J., Maouyo D., Sears C.L. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003, 124:392-400.
124. Wu S., Powell J., Mathioudakis N., Kane S., Fernandez E., Sears C.L. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway. Infect. Immun. 2004, 72:5832-5839.
125. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., Brant S.R., Chakravarti S., Kwon J.H. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135:1624-1635.e24.
126. Wu S., Rhee K.J., Albesiano E., Rabizadeh S., Wu X., Yen H.R., Huso D.L., Brancati F.L., Wick E., McAllister F., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 Tcell responses. Nat. Med. 2009, 15:1016-1022.
127. Xu M., Yamada M., Li M., Liu H., Chen S.G., Han Y.W. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J.Biol. Chem. 2007, 282:25000-25009.
128. Yang Y., Wang X., Huycke T., Moore D.R., Lightfoot S.A., Huycke M.M. Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect. Transl Oncol 2013, 6:596-606.
129. Zaki M.H., Vogel P., Body-Malapel M., Lamkanfi M., Kanneganti T.D. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J.Immunol. 2010, 185:4912-4920.
130. Zarkovic M., Qin X., Nakatsuru Y., Oda H., Nakamura T., Shamsuddin A.M., Ishikawa T. Tumor promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcinogenesis 1993, 14:1261-1264.